Does Sutent shrink tumors?
Five times as many people with renal cell carcinoma (RCC) saw their tumors shrink with Sutent compared with those who were taking interferon α (IFNα). Studies also reported that, on average, people treated with Sutent lived more than twice the number of months without tumor progression compared to those taking IFNα. Overall, clinical trials have proven that Sutent is more effective than IFNα, but some people may not tolerate it well, and it has a black box warning for severe liver toxicity. Sutent is not a cure, and it may not be effective for everybody.
Research has shown:
- Sutent can slow cancer growth and may prevent the spread of cancer cells. Research has shown that Sutent increased the median progression-free survival by 6 months in those with metastatic RCC compared to those treated with IFNα (11 months vs. 5 months)
- Health-related quality of life was better with Sutent compared to the IFNα group according to quality-of-life questionnaires filled out by patients
- When Sutent was used as an add-on treatment for RCC in people who have had a kidney removed, the median disease-free survival was 6.8 years compared to 5.6 years with placebo. Side effects were more common with Sutent compared with placebo
- When Sutent was used to treat patients with GIST, it delayed the time to tumor progression by 21 weeks (time to tumor progression was 27.3 weeks with Sutent and 6.4 weeks with placebo). Progression-free survival was 24.1 weeks with Sutent compared to 6.0 with placebo
- Progression-free survival for patients with pancreatic neuroendocrine tumors (pNET) was 10.2 months with Sutent and 5.4 months with placebo. The objective response rate was 9.3%.
Contact your healthcare provider immediately if you develop any of the following signs and symptoms of liver problems during treatment with Sutent:
- Skin itching
- Yellow eyes or skin
- Dark urine
- Pain or discomfort in the right upper stomach area.
Sutent is an oral capsule that may be taken once daily to treat certain types of RCC and other advanced cancers. It may be taken every day or on 4 weeks on, 2 weeks off schedule. It has been associated with some serious side effects such as liver damage, severe bleeding, cardiovascular events, and osteonecrosis of the jaw. It may cause a yellow tinge to the skin and lighten hair color. It belongs to the class of medicines known as multikinase inhibitors. It may also be called a VEGF/VEGFR inhibitor.
Related questions
References
- Sutent (sunitinib malate). Updated 09/2021. Pfizer Laboratories Div Pfizer Inc https://www.drugs.com/pro/sutent.html
- Sutent capsules. Sutent.com. https://www.sutent.com/advanced-RCC
Read next
What is the success rate of Keytruda?
In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading
How long does it take for Keytruda to work?
The time it takes for Keytruda to work can vary based on the type and stage of cancer. Typically, a response to treatment becomes apparent within 2-4 months of starting Keytruda. This timeframe is referred to as "time to response," which measures when a patient's cancer begins to show signs of responding to the treatment. You can find the specific "time to response" data from clinical trials in the table below. Continue reading
What is the difference between Opdivo and Keytruda?
Opdivo (nivolumab) and Keytruda (pembrolizumab) are two immunotherapy drugs for various cancers. Both are monoclonal antibodies, known as PD1 inhibitors, first approved in 2014. Opdivo is from Bristol Myers Squibb, and Keytruda is from Merck & Co. The main differences lie in dosing, combination therapies, and approved cancer types. Continue reading
Related medical questions
- Pembrolizumab vs. nivolumab: How do they compare?
- How long does it take for Lenvima to work?
- How long do you take Lenvima?
- How does Nexavar work? Is it a chemo drug?
- How much does Afinitor cost per month?
- How are Inlyta and Keytruda used in kidney cancer?
- What is the success rate of Cabometyx (cabozantinib)?
- What is the difference between Mvasi and Avastin?
- How effective is Nexavar? Does it shrink tumors?
- How long can you take Afinitor for?
- Does Votrient cure cancer or shrink tumors?
- What type of drug is Lenvima? Is it a chemo drug?
- How effective are Opdivo and Yervoy when taken together?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- Does Cabometyx (cabozantinib) cure cancer?
- How effective is Lenvima?
- Is Nexavar cost covered by Medicare?
- How long does Votrient stay in your system?
- Is Votrient a chemotherapy treatment?
- Is Votrient immunotherapy?
- What is the difference between Cabometyx and Cometriq?
- Who makes Bavencio and where is it made?
- What type of drug is Bavencio?
Drug information
Related support groups
- Sutent (5 questions, 32 members)
- Sunitinib (2 questions, 12 members)
- Renal Cell Carcinoma (32 questions, 103 members)
- Gastrointestinal Stromal Tumor (9 questions, 20 members)
- Pancreatic Cancer (6 questions, 27 members)